申请人:Seikagaku Corporation
公开号:EP0900569A2
公开(公告)日:1999-03-10
A pharmaceutical composition and an agent that can be used for treatment of epidurally migrating herniated intervertebral disc are provided. The composition comprises a glycosaminoglycan degrading enzyme, preferably chondroitinase, more preferably chondroitinase ABC, in an amount effective to dissolve nucleus pulposus epidurally existing.
本发明提供了一种可用于治疗椎间盘突出症的药物组合物和制剂。该组合物包含一种糖胺聚糖降解酶,优选软骨素酶,更优选软骨素酶 ABC,其用量可有效溶解椎间盘外存在的髓核。